NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger

NewcelX Ltd. ("NewcelX" or the "Company") completed the previously announced merger transaction, pursuant to that certain ...

NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd.

NewcelX Ltd. (Nasdaq: NCEL) ("NewcelX" or the "Company"), a Swiss clinical-stage biopharmaceutical company developing ...
TipRanks on MSN

NLS Pharmaceutics and Kadimastem Complete Merger to Form NewcelX

The latest update is out from NLS Pharmaceutics ( (NLSP) ).
TipRanks on MSN

NLS Pharmaceutics Expands CNS Pipeline with AEX-6xx Series

NLS Pharmaceutics ( ($NLSP) ) has shared an announcement. On October 30, 2025, NLS Pharmaceutics announced the expansion of its DOXA platform with ...
TipRanks on MSN

NLS Pharmaceutics and Kadimastem Finalize Merger Conditions

Detailed price information for Nls Pharmaceutics Ltd (NLSP-Q) from The Globe and Mail including charting and trades.

NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares

NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company") and Kadimastem Ltd. (TASE: KDST) ("Kadimastem") today ...

NLS Pharmaceutics and Kadimastem Announce Strategic Collaboration between Kadimastem and TargetGene to Advance Next-Generation Gene-Edited Cell Therapies

The collaboration will progress under the combined company, NewCelX, upon completion of the anticipated merger ZURICH and NESS ZIONA, Israel, Oct. 27, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasd ...
Benzinga.com

What's Going On With NLS Pharmaceutics Shares Monday?

NLS Pharmaceutics announced it entered into a definitive merger agreement with Kadimastem. One goal of the combined company is to advance NLS's Dual Orexin Agonist platform. See how Matt Maley is ...
Nasdaq

NLS Pharmaceutics Presents Latest Preclinical Pipeline Data at American Society of Clinical Psychopharmacology

ZURICH, SWITZERLAND / ACCESSWIRE / April 25, 2023 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the ...